Anzeige
Mehr »
Login
Montag, 22.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
SolarBank: Sehen Sie sich das Unternehmen an, das in einem Jahr Umsatz von 50 Mio. $ erzielen wird.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CM04 | ISIN: US89455T1097 | Ticker-Symbol:
NASDAQ
19.04.24
21:59 Uhr
10,970 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
TREACE MEDICAL CONCEPTS INC Chart 1 Jahr
5-Tage-Chart
TREACE MEDICAL CONCEPTS INC 5-Tage-Chart

Aktuelle News zur TREACE MEDICAL CONCEPTS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiTreace Medical Concepts, Inc.: Treace to Present at Bank of America Health Care Conference1
DiTreace Medical Concepts, Inc.: Treace Announces First Annual National Bunion Day1
09.04.Treace Medical Concepts, Inc.: Treace to Report First Quarter 2024 Financial Results1
05.03.Earnings call: Treace Medical Concepts reports 32% revenue rise in 20231
28.02.Treace Medical Concepts Inc reports results for the quarter ended in December - Earnings Summary2
27.02.Recap: Treace Medical Concepts Q4 Earnings1
27.02.TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report-
27.02.Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance160PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical...
► Artikel lesen
26.02.Earnings Preview For Treace Medical Concepts1
07.02.Treace Medical Concepts, Inc.: Treace to Report Fourth Quarter and Full-Year 2023 Financial Results1
02.02.Treace Medical Concepts, Inc.: Treace Announces Interim 3-Year ALIGN3D Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure2
01.02.Treace Medical Concepts, Inc.: Treace to Highlight Latest Product Innovations and ALIGN3D Study Outcomes at the 2024 ACFAS Annual Scientific Conference1
08.01.Treace Medical forecasts upbeat Q4, 2023 revenue outlook2
08.01.Treace Medical Concepts rises on preliminary Q4 revenue beat2
08.01.TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report2
08.01.Treace Medical Concepts, Inc.: Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue257PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical...
► Artikel lesen
22.12.236 Analysts Assess Treace Medical Concepts: What You Need To Know2
19.12.23Treace Medical Concepts, Inc.: Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference2
07.12.23Does the New Anti-Obesity Medicine Affect Treace Medical Concepts (TMCI)?1
12.11.23Treace Medical Concepts, Inc. (TMCI) Q3 2023 Earnings Call Transcript2
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1